Welcome to the 1st Edition of “Biotech Startups & Pharma: Strategy, M&A and beyond” Executive Course – a program tailored for individuals aspiring to enhance their expertise and proficiency within the biotech sector, especially those interested in working with the biotech ecosystem and advancing innovation within the field.
This course will equip participants with a comprehensive view on Biotech & Pharma industry – from inception to business scale-up – including Patent Strategy, Clinical Research & Regulatory Framework, Funding and End-to-end M&A journey.
Target Audience
- individuals within the Life Sciences & Healthcare industry seeking to expand their knowledge of biotech startups landscape
- leaders and managers in biotech startups
- entrepreneurs and executives entering the Biotech and Pharma space
- professionals contemplating a career transition to a Strategy, M&A, Corporate Venture Capital or Business Development role
Duration and Venue
15th November to 21st December 2024; Fridays (5 to 7 pm) and Saturdays (9 am-1 pm
This Biotech Startups & Pharma: Strategy, M&A and beyond with 35 hours.
Venue
Católica Medical School
Sintra Campus
Estrada Octávio Pato
2635-631 Rio de Mouro
Main Contents
- Current Pharma Industry Strategy and M&A – Anna Mattson, Partner and Global lead of Life Sciences M&A Strategy and Portfolio Transformation at McKinsey
- From Idea to Exit: Inside a Biotech Startup’s Journey – Nuno Prego Ramos, President and CEO at Valvian, previously at CellmAbs
- Funding and Financing: From Business Angels to IPOs – Raúl Saraiva, Chief Scientific Officer & Venture Partner at 3xP Global
- Protecting Innovation: Intellectual Property – Joana Piriquito Santos, Founding Partner at NLP
- Clinical Trials and Regulatory Framework: Essentials – Helena Corte-Real, VP, Regulatory Portfolio Data & Content Senior Lead at Roche
- Global Biotech Hubs: The Success Story of Basel – Luis Correia, Biotech consultant
- Big Pharma Insights: Mastering M&A Strategy, Valuation, and Execution – Filipe Duarte (M&A Due Dilligence at Novo Nordisk) and José Maçãs (M&A Life Sciences at Deloitte)
- The History of a 3-billion-dollar Company – Jorge Santos Silva, Founder & CEO at MoonLake Immunotherapeutics
- Leadership journey: Pharma, Private Equity and Sovereign Fund Shareholder – Isabel Afonso, CEO at Arcera Life Sciences
Organizing committee
- Daniel Guedelha – Strategic Advisor to Global Pharma and Biotech
- Ana Rita Constante – Coordinator at Católica-Luz Clinical Academic Centre
- João Santos Pereira – Executive Director at Católica Medical School
- José Maçãs – M&A Life Sciences at Deloitte
Do you have any questions or want to know more details about this course?
Please reach out to Daniel Guedelha: dguedelha@ucp.pt
This program is supported by the TRAINING4RESILIENCE project, funded by the European Union (NextGenerationEU), STEAM Youth Impulse and Adult Impulse, as part of the Recovery and Resilience Programme (PRR).
